UTRS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:21):

Stats
Today's Volume	100.00
Average Volume	2 591.00
Market Cap	8 879.00
EPS	$0 ( 2024-03-19 )
Next earnings date	( $0 ) 2024-04-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Cohen Daniel	Buy	0	Common Stock
2023-02-09	New Enterprise Associates 13 Lp	Buy	24 437 927	Common Stock
2023-02-09	Accelmed Partners Ii L.p.	Sell	0	Common Stock
2023-02-09	Geiger Uri	Buy	0	Common Stock
2023-01-02	Usen Todd	Buy	0

INSIDER POWER
100.00
Last 92 transactions
Buy: 38 540 336 \| Sell: 1 194 556

Minerva Surgical, Inc. Correlation

10 Most Positive Correlations
TLGT	0.867
HOWL	0.865
SVAC	0.852
GOODM	0.851
IVA	0.844
NLTX	0.841
MTSL	0.839
VINC	0.839
NVFY	0.837
NSTG	0.833

10 Most Negative Correlations
AMRB	-0.912
LWAC	-0.884
SRAC	-0.841
NETE	-0.831
FLMN	-0.827
LMRKN	-0.822
MMAC	-0.813

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Minerva Surgical, Inc. Financials

Annual	2022
Revenue:	$50.29M
Gross Profit:	$27.24M (54.17 %)
EPS:	$-23.68

Q3	2023
Revenue:	$11.97M
Gross Profit:	$6.22M (51.97 %)
EPS:	$-0.810

Q2	2023
Revenue:	$13.39M
Gross Profit:	$7.40M (55.28 %)
EPS:	$-0.980

Q1	2023
Revenue:	$12.53M
Gross Profit:	$7.02M (55.97 %)
EPS:	$-2.81

Financial Reports:

No articles found.

Minerva Surgical, Inc.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Realtime updates for Minerva Surgical, Inc. [UTRS]

Upcoming Earnings Alert